Location: Home
  • search
  • go
  • Relate News
  • 12/25/2018China Removes Import Tariff of 700 Items Including At Least 50+ Drug I...
  • 12/24/2018China Biotech: Six Things to Watch in 2019
  • 12/24/2018Draft Patent Law Amendment Under First Review by the NPC (with Key Pha...
  • 12/24/2018NPC Reviews Draft Foreign Investment Law to Ban Forced Technology Tran...
  • 12/24/2018NMPA Publishes the Second List of Drugs with Expired, Terminated or In...
  • 12/24/2018Draft Vaccine Law Submitted to the Chinese Legislature for Review
  • 12/24/2018NHC: National S&T Major Project for New Drug R&D Harvests Abun...
  • 12/23/2018Bayer Receives Approval in China for Endometriosis Treatment Visanne
  • 12/23/2018Recent Executive Moves
  • 12/21/2018NMPA Issues the Guidelines for Individual ADR Case Collection and Repo...
  • 12/21/2018SMIA Initiates Process for National DRG Trial
  • 12/20/2018HitGen and Bayer Enter DNA-Encoded Library Based Research Collaboratio...
  • 12/20/2018IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q3/2018
  • 12/20/2018China to Introduce Implementation Rules for 4+7 National Volume-linked...
  • 12/20/2018NMPA Solicits Comments on Draft Requirements for Import Drug Standard ...
  • 12/20/2018Servier Launches Project Umbrella to Support Cardiovascular Disease Ma...
  • 12/20/2018China's Health Protection Gap Largest in Asia
  • 12/19/2018Ziopharm Oncology and TriArm to Form Joint Venture for China and Korea
  • 12/19/2018AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partn...
  • 12/19/2018China's Junshi Biosciences raises $394 mln after pricing IPO at bottom...
  • 12/19/2018Novartis, Gan & Lee Push into Insulin amid Diabetes Epidemic
  • 12/19/2018Ascentage Pharma Announces Strategic Collaboration with Genor Biopharm...
  • 12/19/2018Auransa and Lee's Pharma Enter Agreement for AU018 in Greater China an...
  • 12/19/2018Pfizer and GSK Announce JV to Create a Global Consumer Healthcare Gian...
  • 12/18/2018New Pfizer CEO's Top Priorities? Think China and Pipeline, Not Deals
  • 12/18/2018Bridge Bio and Daewoong Enter US$40M License Deal for UC Drug Candidat...
  • 12/18/2018Anji Pharma Licenses Regional Rights to a Clinical Asset from Novartis
  • 12/18/2018China's Win-At-All-Costs Approach Suggests It Will Follow Its Own Dang...
  • 12/18/2018Gilead Sciences Takes Off in China with Commitment to Cure Hepatitis
  • 12/18/2018Grifols Eyes $5B Takeover of Shanghai RAAS Blood Products
  • Page:329/805 Total number of articles:24134: [First][<<] [327] [328] [329] [330] [331] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group